Center-Authored Papers

Filters: Author is Qin, Li  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT et al..  2008.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.. Journal of virology. 82(24):12449-63. Abstract
Gilbert PB, Qin L, Self SG.  2008.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
Qin L, Gilbert PB, Follmann D, Li D.  2008.  ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL.. The annals of applied statistics. 2(1):386-407. Abstract
2009
Qin L, Guo W, Litt B.  2009.  A Time-Frequency Functional Model for Locally Stationary Time Series Data.. Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America. 18(3):675-693. Abstract
Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D et al..  2009.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.. Journal of virology. 83(8):3719-33. Abstract
Gilbert PB, Qin L, Self SG.  2009.  Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.. Statistics in medicine. 28(4):716-9.
2010
Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E, Dibben O, Stacey A, Fellay J, Shianna KV et al..  2010.  Evidence of dysregulation of dendritic cells in primary HIV infection.. Blood. 116(19):3839-52. Abstract
Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS.  2010.  Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.. Journal of virology. 84(12):6096-102. Abstract
Stoffer DS, Han S, Qin L, Guo W.  2010.  Smoothing spline ANOPOW. Journal of Statistical Planning and Inference. 140(12):3789-3796.
Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ et al..  2010.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.. PLoS pathogens. 6(5):e1000893. Abstract
2011
Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC et al..  2011.  Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.. PloS one. 6(9):e24517. Abstract
2013
Chen X, Bailleux F, Desai K, Qin L, Dunning AJ.  2013.  A threshold method for immunological correlates of protection.. BMC medical research methodology. 13(1):29. Abstract
Acute Disease
Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS.  2010.  Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.. Journal of virology. 84(12):6096-102. Abstract
Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ et al..  2010.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.. PLoS pathogens. 6(5):e1000893. Abstract
Acute-Phase Proteins
Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ et al..  2010.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.. PLoS pathogens. 6(5):e1000893. Abstract
Adult
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
AIDS Vaccines
Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ et al..  2010.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.. PLoS pathogens. 6(5):e1000893. Abstract
Gilbert PB, Qin L, Self SG.  2008.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
Algorithms
Gilbert PB, Qin L, Self SG.  2008.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
alpha 1-Antitrypsin
Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ et al..  2010.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.. PLoS pathogens. 6(5):e1000893. Abstract
Antibodies, Viral
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
B-Lymphocytes
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT et al..  2008.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.. Journal of virology. 82(24):12449-63. Abstract
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
Biological Markers
Gilbert PB, Qin L, Self SG.  2009.  Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.. Statistics in medicine. 28(4):716-9.